An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
about
Regenerative Capacity of Macrophages for RemyelinationMyelin regulatory factor drives remyelination in multiple sclerosis.Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.Fibrinogen Activates BMP Signaling in Oligodendrocyte Progenitor Cells and Inhibits Remyelination after Vascular Damage.Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic.Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation.Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis.Deficiency of TREK-1 potassium channel exacerbates secondary injury following spinal cord injury in mice.Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?Regenerating CNS myelin - from mechanisms to experimental medicines.Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury.The Biology of Regeneration Failure and Success After Spinal Cord Injury.Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.The Extracellular Matrix and Remyelination Strategies in Multiple Sclerosis.DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis
P2860
Q26744475-511DC4AD-C0E4-4EB6-BA38-B08FC1D88922Q38718081-68D88B4B-C690-41F1-B88D-B75CBDC4270BQ39146141-309B927D-7972-4572-AE14-A42879AF511DQ46448356-48663641-B245-4887-BA61-ABBB602B7E48Q47134235-73B830CF-8160-412F-A324-0F009B054D9DQ47155362-DFDC7EF8-CC57-47FB-9DCE-09BA75D49278Q47200107-03E19847-AD14-4BD1-B03D-EF34A74F3892Q47970704-04AB70A2-0C6A-464D-8986-7485BD9103D9Q48001723-6ABF9298-4673-4156-8551-783CC40D2A3EQ48132838-65D9F6AD-5ECF-4BF7-9CC9-5FD674C1F04FQ49986398-AAF1527C-640E-467C-979E-D80702487B60Q52646465-380F6197-6DD2-44A7-81EC-8FE33626C306Q52669755-2B50599C-A5EB-4F05-919C-2812E2A4E59AQ52673695-AD1A4B3E-43B6-4621-BBA4-6FC31332C637Q55097614-6DC943E9-C157-4C24-982D-E1C8A68281FAQ55223367-B9249F12-2743-4D96-BA7E-5E1B183939C9Q55262746-C61FF3A5-598F-4421-B6F4-469F894D591BQ57295496-B9D99B54-341C-4768-B7B6-92702E913ED6
P2860
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
An inhibitor of chondroitin su ...... nervous system remyelination.
@ast
An inhibitor of chondroitin su ...... nervous system remyelination.
@en
type
label
An inhibitor of chondroitin su ...... nervous system remyelination.
@ast
An inhibitor of chondroitin su ...... nervous system remyelination.
@en
prefLabel
An inhibitor of chondroitin su ...... nervous system remyelination.
@ast
An inhibitor of chondroitin su ...... nervous system remyelination.
@en
P2093
P2860
P50
P356
P1476
An inhibitor of chondroitin su ...... nervous system remyelination.
@en
P2093
Chang-Chun Ling
Erin L Stephenson
James A Rogers
Lorraine W Lau
Michael B Keough
Mitchel G Hurlbert
Ping Zhang
Samuel K Jensen
Tieyu Chen
P2860
P2888
P356
10.1038/NCOMMS11312
P407
P577
2016-04-26T00:00:00Z